xanthinol niacinate has been researched along with Brain Vascular Disorders in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (80.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| JENSEN, BS | 1 |
| FRUHMANN, H | 1 |
| LAWRENCE, RM; LEICHMAN, NS | 1 |
| LOOS, M | 1 |
| CORA, R; FLUEGEL, KA; MENGI, E | 1 |
| Grobe-Einsler, R; Lehmann, E; Linden, M; van der Crone, L | 1 |
| Klieser, E; Lehmann, E | 1 |
| Brückner, GW; Jansen, W | 1 |
| Kostiuchenko, VG; Man'kovskiĭ, NB; Tereshchenko, LA | 1 |
| Herrschaft, H | 1 |
| Demeter, J; Molnár, L; Túry, F; Vámosi, B | 1 |
| Haupt, R; Isermann, H | 1 |
| Gritsaĭ, NN; Vesel'skiĭ, ISh | 1 |
| Bulakhova, LA; Martyniuk, VIu | 1 |
| Berdichevskiĭ, MIa; Dronnikova, IS; Onopchenko, NV | 1 |
1 review(s) available for xanthinol niacinate and Brain Vascular Disorders
| Article | Year |
|---|---|
[Therapy of inadequate cerebral circulation].
Topics: Actihaemyl; Anticoagulants; Bencyclane; Brain Edema; Cerebrovascular Circulation; Cerebrovascular Disorders; Dexamethasone; Dextrans; Ergot Alkaloids; Hexobendine; Humans; Ischemic Attack, Transient; Meclofenoxate; Nicotinyl Alcohol; Papaverine; Pyrithioxin; Theophylline; Xanthinol Niacinate; Yohimbine | 1976 |
4 trial(s) available for xanthinol niacinate and Brain Vascular Disorders
| Article | Year |
|---|---|
Drug monitoring study (phase IV) of xantinolnicotinate (Complamin) in general practice.
Topics: Aged; Cerebrovascular Disorders; Dementia; Humans; Xanthinol Niacinate | 1993 |
Drug monitoring studies as a method of analyzing response criteria.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Cerebrovascular Disorders; Depressive Disorder; Drug Monitoring; Drug Prescriptions; Female; Fluoxetine; Humans; Male; Middle Aged; Research Design; Vasodilator Agents; Xanthinol Niacinate | 1997 |
[Therapy of cerebrovascular insufficiency. A psychometric double-blind trial with a slow-release form of xantinol nicotinate (author's transl)].
Topics: Aged; Attention; Cerebrovascular Disorders; Double-Blind Method; Drug Evaluation; Female; Geriatrics; Humans; Interpersonal Relations; Male; Memory; Theophylline; Xanthinol Niacinate | 1979 |
Comparative study of the effect of ethyl apovincaminate and xantinol nicotinate in cerebrovascular diseases. Immediate drug effects on the concentrations of carbohydrate metabolites and electrolytes in blood and CSF.
Topics: Brain; Cerebrovascular Disorders; Electrolytes; Glucose; Glycolysis; Humans; Oxygen Consumption; Paralysis; Theophylline; Vinca Alkaloids; Xanthinol Niacinate | 1976 |
10 other study(ies) available for xanthinol niacinate and Brain Vascular Disorders
| Article | Year |
|---|---|
[ON COMPLAMIN].
Topics: Brain Injuries; Cerebrovascular Disorders; Facial Paralysis; Humans; Neuritis; Niacin; Nicotinic Acids; Theophylline; Trigeminal Neuralgia; Xanthinol Niacinate | 1963 |
[ON THE TREATMENT OF APOPLEXY WITH COMPLAMIN (7-(2-HYDROXY-3-(N-2-HYDROXYETHYL-N-METHYLAMINO)PROPYL)THEOPHYLLINE NICOTINATE].
Topics: Cerebrovascular Disorders; Geriatrics; Humans; Niacin; Nicotinic Acids; Stroke; Theophylline; Xanthinol Niacinate | 1963 |
COMPARISON OF THE EFFECTS OF HEPARIN SODIUM, XANTHINOL NIACINATE (COMPLAMIN) AND 2-DIMETHYL-AMINOETHANOL (DEANER) IN INSTITUTIONALIZED GERIATRIC GROUPS.
Topics: Antidepressive Agents; Behavior; Biomedical Research; Cerebrovascular Disorders; Deanol; Depression; Depressive Disorder; Drug Therapy; Geriatrics; Heparin; Intracranial Arteriosclerosis; Memory; Niacin; Nursing; Psychological Tests; Theophylline; Toxicology; Xanthinol Niacinate | 1965 |
[ON THE TREATMENT OF CEREBRAL AND PERIPHERAL CIRCULATORY DISORDERS. (REPORT ON CLINICAL EXPERIENCES WITH COMPLAMIN)].
Topics: Cardiovascular Diseases; Cerebrovascular Disorders; Drug Therapy; Niacin; Nicotinic Acids; Theophylline; Vascular Diseases; Xanthinol Niacinate | 1964 |
[CLINICO-ELECTROENCEPHALOGRAPHIC FINDINGS IN VASOACTIVE TREATMENT WITH COMPLAMIN].
Topics: Cerebral Cortex; Cerebrovascular Disorders; Drug Therapy; Electroencephalography; Neurologic Manifestations; Niacin; Nicotinic Acids; Theophylline; Toxicology; Xanthinol Niacinate | 1964 |
[Use of complamin in complex rehabilitation treatment of post-stroke patients of older age groups].
Topics: Age Factors; Aged; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Humans; Male; Middle Aged; Theophylline; Xanthinol Niacinate | 1978 |
[Learning and concentration abilities of elderly patients with the depressive syndrome in cerebrovascular circulation disorders].
Topics: Attention; Cerebrovascular Disorders; Depression; False Positive Reactions; Hospitalization; Humans; Learning; Middle Aged; Psychological Tests; Theophylline; Xanthinol Niacinate | 1976 |
[The correction of lipid peroxidation metabolism, the hemostatic system and cerebral hemodynamics in patients with the initial manifestations of cerebral circulatory insufficiency].
Topics: Adult; Cerebrovascular Circulation; Cerebrovascular Disorders; Drug Evaluation; Female; Hemodynamics; Hemostasis; Humans; Lipid Peroxidation; Male; Middle Aged; Nicergoline; Xanthinol Niacinate | 1992 |
[Value of complamin and seduxen in the correction of hemodynamic disorders of epileptic children and adolescents].
Topics: Adolescent; Anticonvulsants; Brain; Cerebrovascular Disorders; Child; Diazepam; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Plethysmography, Impedance; Regional Blood Flow; Theophylline; Xanthinol Niacinate; Xenon Radioisotopes | 1987 |
[Effect of a series of vasoactive drugs on the compensatory adaptive processes of the brain during acute experimental cerebral venous stasis].
Topics: Adaptation, Physiological; Aminophylline; Animals; Brain; Cerebrovascular Disorders; Hydroxyethylrutoside; Pentoxifylline; Rats; Vasodilator Agents; Vinca Alkaloids; Xanthinol Niacinate | 1987 |